Local Institution

Spokane, Washington 99204

0 studies enrolling now · 20 studies all time

What they study most

Bipolar Disorder, Chronic Myeloid Leukemia, Congestive Heart Failure, Diabetes Mellitus, Diabetes Mellitus II, Diabetes Mellitus, Type 2, Diabetes, Type 2, HIV Infections, Heart Disease, Hypertension, Ischemic Heart Disease, Kawasaki Disease

Studies at this site

• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease — Completed
• A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography — Stopped early
• A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
• Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone — Completed
• Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
• Aripiprazole Open-Label, Safety and Tolerability Study — Completed
• Aripiprazole in Adolescents With Schizophrenia — Completed
• Aripiprazole in Children and Adolescents With Bipolar I Disorder — Completed
• A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control — Completed
• PPAR - Combination With Metformin — Completed
• Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
• Atazanavir for HIV Infected Individuals: An Early Access Program — NO_LONGER_AVAILABLE
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed
• A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed
• Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone — Completed
• Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia — Completed
• A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate — Completed